OptiScan Biomedical Completes $20 Million Series E Financing
Proceeds to Support U.S. Commercialization of OptiScanner 5000 and Ongoing Platform Expansion Company’s First-of-its-Kind Continuous Monitoring Platform for Intensive Care Units to be Highlighted [...]